DigestRedComo funciona
Red
/
Empresas
Id
No verificado

Idorsia Pharmaceuticals Ltd

Sobre qué escribimos

Anuncios brevesFarmacéutica

80 Comunicados de prensa

Ver todos los comunicados de prensa
29/07/2026
Farmacéutica
Anuncios breves
QUVIVIQ sales increased 62% year-on-year as Idorsia advances key drivers of future growth
Fuente
Idorsia Pharmaceuticals Ltd
Editor
GLOBENEWSWIRE
1.00
0
26/07/2026
Farmacéutica
Anuncios breves
Idorsia advances global rollout of QUVIVIQ with Jamjoom Pharma partnership in Saudi Arabia and the Levant
Fuente
Idorsia Pharmaceuticals Ltd
Editor
GLOBENEWSWIRE
1.00
0
23/07/2026
Farmacéutica
Anuncios breves
Invitation to Idorsia's HY 2026 Financial Reporting webcast and conference call
Fuente
Idorsia Pharmaceuticals Ltd
Editor
GLOBENEWSWIRE
1.00
0
30/06/2026
Farmacéutica
Anuncios breves
Idorsia appoints Roland Wandeler as Chief Executive Officer
Fuente
Idorsia Pharmaceuticals Ltd
Editor
GLOBENEWSWIRE
1.00
0
25/06/2026
Farmacéutica
Anuncios breves
Idorsia confirms successful closing of Pharmakon loan agreement and full repayment of New Money Facility
Fuente
Idorsia Pharmaceuticals Ltd
Editor
GLOBENEWSWIRE
1.00
0
08/06/2026
Farmacéutica
Anuncios breves
Idorsia strengthens financial position with up to CHF 250 million loan from Pharmakon
Fuente
Idorsia Pharmaceuticals Ltd
Editor
GLOBENEWSWIRE
1.00
0
31/05/2026
Farmacéutica
Anuncios breves
Idorsia reports new positive results with its breakthrough C. difficile vaccine – underscoring the unique potential of its glycan technology
Fuente
Idorsia Pharmaceuticals Ltd
Editor
GLOBENEWSWIRE
1.00
0
31/05/2026
Farmacéutica
Anuncios breves
New analysis of Idorsia’s aprocitentan demonstrates significant and sustained reduction in albuminuria in patients with uncontrolled / resistant hypertension
Fuente
Idorsia Pharmaceuticals Ltd
Editor
GLOBENEWSWIRE
1.00
0
06/05/2026
Farmacéutica
Anuncios breves
Shareholders vote in favor of all proposals by the Board at Idorsia’s Annual General Meeting 2026
Fuente
Idorsia Pharmaceuticals Ltd
Editor
GLOBENEWSWIRE
1.00
0
27/04/2026
Farmacéutica
Anuncios breves
Idorsia reports strong Q1 2026 performance with 74% QUVIVIQ sales growth year-on-year
Fuente
Idorsia Pharmaceuticals Ltd
Editor
GLOBENEWSWIRE
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0